Cilengitide-Induced Temporal Variations in Transvascular Transfer Parameters of Tumor Vasculature in a Rat Glioma Model: Identifying Potential MRI Biomarkers of Acute Effects

作者: Tavarekere N. Nagaraja , Madhava P. Aryal , Stephen L. Brown , Hassan Bagher-Ebadian , Tom Mikkelsen

DOI: 10.1371/JOURNAL.PONE.0084493

关键词: Magnetic resonance imagingVascular permeabilityPathologyIntegrinImmunohistochemistryRadiation therapyGliomaMedicineVon Willebrand factorCilengitide

摘要: Increased efficacy of radiotherapy (RT) 4-8 h after Cilengitide treatment has been reported. We hypothesized that the effects on tumor transvascular transfer parameters might underlie, and thus predict, this potentiation. Athymic rats with orthotopic U251 glioma were studied at ~21 days implantation using dynamic contrast-enhanced (DCE)-MRI. Vascular parameters, viz: plasma volume fraction (vp), forward constant (Ktrans) interstitial (ve) a contrast agent, determined in vasculature once before, again cohorts 2, 4, 8, 12 24 administration (4 mg/kg; N = 31; 6-7 per cohort). Perfusion-fixed brain sections stained for von Willebrand factor to visualize vascular segments. A comparison pre- post-treatment showed differences between MR indices before pivoted around 8 time point, 2 4 groups showing increases, decreases, values point close baseline. The parameter group significant Ktrans (p 0.0001 ve 0,0271). staining little variation Cilengitide. normalization occurring coincided similar previous reports increased when RT followed by h. Pharmacological potential increase sensitivity RT. Evaluating acute temporal responses putative anti-angiogenic drugs may help optimizing their combination other modalities.

参考文章(42)
Andrea Carter, Integrins as Target: First Phase III Trial Launches, but Questions Remain Journal of the National Cancer Institute. ,vol. 102, pp. 675- 677 ,(2010) , 10.1093/JNCI/DJQ186
Serena Desideri, Louis B. Nabors, Myrna Rosenfeld, Joy Fisher, , Stuart A. Grossman, Xiaobu Ye, Steven Piantadosi, Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States Clinical Cancer Research. ,vol. 16, pp. 2443- 2449 ,(2010) , 10.1158/1078-0432.CCR-09-3106
Freddy E. Escorcia, Erik Henke, Michael R. McDevitt, Carlos H. Villa, Peter Smith-Jones, Ronald G. Blasberg, Robert Benezra, David A. Scheinberg, Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors Cancer Research. ,vol. 70, pp. 9277- 9286 ,(2010) , 10.1158/0008-5472.CAN-10-2029
Roger Stupp, Monika E Hegi, Thierry Gorlia, Sara Erridge, Danica Grujicic, Joachim Peter Steinbach, Wolfgang Wick, Rafal Tarnawski, Do-Hyun Nam, Astrid Weyerbrock, Peter Hau, Martin JB Taphoorn, Louis B Nabors, David A Reardon, Martin J Van Den Bent, James R Perry, Yong Kil Hong, Christine Hicking, Martin Picard, Michael Weller, European Organisation for Research and Treatment of Cancer (EORTC), the Canadian Brain Tumor Consortium, and the CENTRIC Study Team, Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. Journal of Clinical Oncology. ,vol. 31, ,(2013) , 10.1200/JCO.2013.31.18_SUPPL.LBA2009
Christian Mawrin, Elmar Kirches, Anette Wilisch-Neumann, Integrin inhibition as a potential target for invasive meningiomas. Journal of Clinical Oncology. ,vol. 31, ,(2013) , 10.1200/JCO.2013.31.15_SUPPL.E22140
Tavarekere N. Nagaraja, Robert A. Knight, James R. Ewing, Kishor Karki, Vijaya Nagesh, Joseph D. Fenstermacher, Multiparametric Magnetic Resonance Imaging and Repeated Measurements of Blood-Brain Barrier Permeability to Contrast Agents Methods in Molecular Biology. ,vol. 686, pp. 193- 212 ,(2011) , 10.1007/978-1-60761-938-3_8
Madhava P. Aryal, Tavarekere N. Nagaraja, Kelly A. Keenan, Hassan Bagher-Ebadian, Swayamprava Panda, Stephen L. Brown, Glauber Cabral, Joseph D. Fenstermacher, James R. Ewing, Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T. Magnetic Resonance in Medicine. ,vol. 71, pp. 2206- 2214 ,(2014) , 10.1002/MRM.24873
Hidemitsu Nakagawa, Dennis R. Groothuis, Ernest S. Owens, Joseph D. Fenstermacher, Clifford S. Patlak, Ronald G. Blasberg, Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain. Journal of Cerebral Blood Flow and Metabolism. ,vol. 7, pp. 687- 701 ,(1987) , 10.1038/JCBFM.1987.123
David A Reardon, L Burt Nabors, Roger Stupp, Tom Mikkelsen, Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme Expert Opinion on Investigational Drugs. ,vol. 17, pp. 1225- 1235 ,(2008) , 10.1517/13543784.17.8.1225